A biomarker is any measurable characteristic of biological function. In aging medicine, biomarkers serve two critical purposes: they reveal how your body is actually functioning (independent of how you feel), and they provide an objective basis for tracking whether interventions are working.
The difference between guesswork and evidence-based anti-aging medicine is biomarker testing.
Why Symptoms Are Not Enough
The problem with relying on symptoms to understand aging is that age-related biological decline is slow and adaptive. Your body compensates for hormonal decline, mitochondrial inefficiency, and immune aging gradually enough that the subjective experience lags significantly behind the objective change.
A man whose testosterone has declined from 700 ng/dL at age 30 to 380 ng/dL at age 50 may not feel dramatically different from week to week. But over that twenty years, the effects on his muscle mass, fat distribution, libido, cognitive function, and cardiovascular risk have been accumulating steadily.
Biomarker testing reveals these changes early, before they produce symptoms severe enough to prompt a visit to a doctor for a disease diagnosis.
The Key Biomarkers for Aging and Longevity
GH/IGF-1 Axis
IGF-1 is the primary measurable downstream marker of GH axis function. IGF-1 peaks in the mid-twenties and declines approximately 15% per decade thereafter. A low-normal or below-range IGF-1 at age 45 indicates clinically significant GH axis decline affecting muscle, fat, bone, recovery, and cognitive function.
- Normal reference range: 100 to 300 ng/mL (varies by lab and age; Longegra physicians interpret results in the context of your age and clinical picture)
- Target for longevity: Upper quartile of the normal range for your age
Hormonal Axis
- Total and free testosterone (men): Primary anabolic and androgenic hormone. Affects muscle, fat distribution, libido, mood, and cardiovascular risk.
- DHEA-S: The most abundant adrenal androgen. Declines markedly with age and serves as a general marker of adrenal reserve and biological vitality.
- Thyroid panel (TSH, free T3, free T4): Thyroid function drives metabolic rate and cellular energy. Subclinical hypothyroidism is common and often undiagnosed.
- Oestradiol (men): Relevant for cardiovascular and bone health in men; elevated oestradiol (often from testosterone aromatisation in obesity) is a marker of metabolic dysfunction.
Inflammatory Status
- hsCRP (high-sensitivity C-reactive protein): The primary marker of systemic low-grade inflammation (inflammaging). Levels above 1.0 mg/L indicate meaningful inflammatory burden.
- IL-6: A cytokine that drives chronic inflammation and is directly associated with frailty and mortality risk in aging populations.
- Fibrinogen: An elevated level indicates chronic inflammatory and coagulation activation.
Metabolic Health
- HbA1c: Three-month average blood glucose. Values above 5.7% indicate prediabetes. Elevated HbA1c accelerates biological aging through glycation damage.
- Fasting insulin: More sensitive than fasting glucose for detecting early insulin resistance.
- Lipid panel (LDL, HDL, triglycerides, ApoB): ApoB is increasingly recognised as a superior cardiovascular risk marker compared to standard LDL cholesterol.
Cellular and Mitochondrial Markers
- NAD+ levels: Measurable through specialised testing. Declining NAD+ indicates mitochondrial aging and impaired DNA repair capacity.
- Telomere length: Available through commercial testing. Provides a direct measure of cellular replicative capacity.
- Epigenetic age (Horvath clock, GrimAge): The most accurate current measure of biological age, available through specialist laboratories.
How Biomarkers Guide Peptide Protocol Design
The clinical value of biomarkers is in protocol design: knowing which systems are most out of range directs which interventions are highest priority.
| Biomarker Finding | Clinical Implication | Protocol Response |
|---|---|---|
| Low IGF-1 | GH axis decline | CJC-1295 + ipamorelin |
| Low testosterone | Hormonal decline | Testosterone support peptides (kisspeptin, enclomiphene) |
| Elevated hsCRP | Inflammaging | GHK-Cu, BPC-157, lifestyle optimisation |
| Elevated HbA1c | Metabolic dysfunction | GLP-1 peptides, metabolic protocol |
| Low DHEA-S | Adrenal aging | DHEA supplementation, stress reduction protocol |
| Low NAD+ | Mitochondrial aging | NAD+ precursors (NMN/NR) |
Tracking Biomarkers Over Time
The greatest value of biomarker testing is longitudinal: comparing your results against your own baseline over time to see whether your biological age trajectory is improving, stable, or declining.
Longegra's programs include baseline testing at intake, and scheduled retesting at three and six months. This allows protocol adjustment based on measured response rather than assumptions.
Frequently Asked Questions (FAQs)
IGF-1 is the single most impactful age-related biomarker because of the breadth of its downstream effects. Testosterone and hsCRP are close second priorities for men. For a comprehensive picture, a panel covering all the domains above is required.
